tiprankstipranks
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market

MoonLake Immunotherapeutics (MLTX) Financial Statements

Compare
319 Followers

MoonLake Immunotherapeutics Financial Overview

MoonLake Immunotherapeutics's market cap is currently $2.74B. The company's EPS TTM is $-1.291; its P/E ratio is ―; MoonLake Immunotherapeutics is scheduled to report earnings on March 24, 2025, and the estimated EPS forecast is $-0.62. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -13.16K$ -12.36K$ -4.97K$ 0.00
Operating Income$ -54.12M$ -65.06M$ -53.58M$ -105.76K
EBITDA$ -54.11M$ -65.05M$ -53.63M$ -90.84K
Net Income$ -36.01M$ -64.51M$ -53.64M$ -90.84K
Balance Sheet
Cash & Short-Term Investments$ 511.01M$ 72.11M$ 8.04M$ 1.34M
Total Assets$ 526.54M$ 76.84M$ 9.68M$ 116.63M
Total Debt$ 3.81M$ 282.58K$ 15.00M$ 58.06K
Net Debt$ -447.36M$ -39.22M$ 6.96M$ -1.28M
Total Liabilities$ 13.05M$ 8.08M$ 21.33M$ 4.15M
Stockholders' Equity$ 495.68M$ 48.90M$ -11.65M$ 112.48M
Cash Flow
Free Cash Flow$ -43.06M$ -55.91M$ -35.23M$ -316.69K
Operating Cash Flow$ -42.78M$ -55.89M$ -35.18M$ -316.69K
Investing Cash Flow$ -25.18M$ -32.34M$ -50.71K$ -115.00M
Financing Cash Flow$ 479.70M$ 119.69M$ 43.26M$ 116.65M
Currency in USD

MoonLake Immunotherapeutics Earnings and Revenue History

MoonLake Immunotherapeutics Debt to Assets

MoonLake Immunotherapeutics Cash Flow

MoonLake Immunotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis